X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19383) 19383
Newsletter (1436) 1436
Newspaper Article (847) 847
Government Document (16) 16
Magazine Article (14) 14
Book Chapter (9) 9
Book / eBook (7) 7
Dissertation (6) 6
Publication (6) 6
Conference Proceeding (5) 5
Journal / eJournal (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16872) 16872
male (13251) 13251
prostate cancer (11731) 11731
cancer (9349) 9349
oncology (8901) 8901
animals (5321) 5321
middle aged (4963) 4963
prostatic neoplasms - pathology (4951) 4951
aged (4801) 4801
research (4553) 4553
prostate (4500) 4500
cell line, tumor (4288) 4288
female (4025) 4025
tumors (3958) 3958
metastasis (3776) 3776
medicine (3770) 3770
prostate-cancer (3646) 3646
research article (3558) 3558
mice (3515) 3515
multidisciplinary sciences (3381) 3381
science (3381) 3381
prostatic neoplasms - immunology (3352) 3352
expression (3158) 3158
analysis (2882) 2882
gene expression (2748) 2748
proteins (2630) 2630
care and treatment (2610) 2610
urology & nephrology (2479) 2479
prostatic neoplasms - metabolism (2476) 2476
apoptosis (2473) 2473
prostatic neoplasms - genetics (2296) 2296
health aspects (2199) 2199
oncology, experimental (2150) 2150
adult (2136) 2136
prognosis (2087) 2087
immunology (2046) 2046
immunotherapy (1980) 1980
breast cancer (1958) 1958
genetic aspects (1954) 1954
cell biology (1819) 1819
development and progression (1814) 1814
immunohistochemistry (1796) 1796
biology (1787) 1787
carcinoma (1772) 1772
risk factors (1731) 1731
aged, 80 and over (1729) 1729
cancer therapies (1725) 1725
medical research (1711) 1711
cancers and neoplasms (1705) 1705
metastases (1670) 1670
breast-cancer (1658) 1658
antigens (1647) 1647
pathology (1647) 1647
gene expression regulation, neoplastic (1638) 1638
signal transduction (1614) 1614
urology (1565) 1565
prostatic neoplasms - therapy (1564) 1564
diagnosis (1560) 1560
patients (1527) 1527
cell proliferation (1518) 1518
prostatic neoplasms - diagnosis (1498) 1498
prostatic neoplasms - drug therapy (1484) 1484
kinases (1479) 1479
survival (1475) 1475
genes (1469) 1469
prostate-specific antigen (1464) 1464
studies (1445) 1445
prostate-specific antigen - blood (1444) 1444
biomarkers (1406) 1406
chemotherapy (1390) 1390
endocrinology & metabolism (1360) 1360
cells (1301) 1301
growth (1285) 1285
medical prognosis (1284) 1284
risk (1253) 1253
surgery (1212) 1212
biochemistry (1173) 1173
medicine and health sciences (1155) 1155
progression (1121) 1121
medicine & public health (1118) 1118
treatment outcome (1114) 1114
androgens (1103) 1103
cell cycle (1090) 1090
genetics (1085) 1085
prostatic neoplasms - surgery (1085) 1085
disease progression (1074) 1074
medicine, research & experimental (1065) 1065
neoplasm staging (1062) 1062
biopsy (1061) 1061
therapy (1052) 1052
biology and life sciences (1051) 1051
activation (1017) 1017
biochemistry & molecular biology (1003) 1003
cell growth (1001) 1001
prostate - pathology (984) 984
radical prostatectomy (969) 969
mortality (964) 964
cancer research (950) 950
adenocarcinoma (949) 949
lung cancer (935) 935
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21387) 21387
Japanese (114) 114
French (89) 89
German (71) 71
Chinese (50) 50
Russian (48) 48
Spanish (43) 43
Italian (19) 19
Norwegian (18) 18
Hungarian (17) 17
Portuguese (8) 8
Swedish (7) 7
Danish (5) 5
Dutch (4) 4
Bulgarian (2) 2
Czech (2) 2
Polish (2) 2
Romanian (2) 2
Turkish (2) 2
Croatian (1) 1
Hebrew (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 676 - 681
Abstract We wanted to determine whether allogeneic hematopoietic stem cell transplantation (HSCT) may result in long-term survival in patients with solid... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Allogeneic hematopoietic stem cell transplantation | Colon carcinoma | Renal carcinoma | Cholangiocarcinoma | DONOR | BONE-MARROW | GRAFT | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | BREAST-CANCER | PRIMARY LIVER-CANCER | LEUKEMIA | HEMATOLOGY | COLON-CARCINOMA | MARROW TRANSPLANTATION | BLOOD | Adenocarcinoma - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Bile Duct Neoplasms - immunology | Neoplasm Metastasis | Graft vs Host Disease - mortality | Colonic Neoplasms - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Transplantation Conditioning - methods | Graft vs Host Disease - diagnosis | Kidney Neoplasms - therapy | Colonic Neoplasms - therapy | Prostatic Neoplasms - pathology | Colonic Neoplasms - mortality | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Kidney Neoplasms - mortality | Myeloablative Agonists | Prostatic Neoplasms - mortality | Graft vs Host Disease - pathology | Bile Duct Neoplasms - therapy | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Bile Duct Neoplasms - mortality | Colonic Neoplasms - pathology | Pancreatic Neoplasms - immunology | Survival Analysis | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Aged | Bile Duct Neoplasms - pathology | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Liver cancer | Colon cancer | Pancreatic cancer | Liver | Mortality | Stem cells | Transplantation | Metastasis | Health aspects | Prostate cancer | Risk factors | Hematopoietic stem cells | College teachers
Journal Article
Prostate cancer and prostatic diseases, ISSN 1365-7852, 1997
Journal
Molecular therapy, ISSN 1525-0016, 2014, Volume 22, Issue 1, pp. 18 - 27
... Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; 2Tumor Angiogenesis Program, Sir Peter... 
MEDICINE, RESEARCH & EXPERIMENTAL | BREAST-CANCER METASTASIS | TOLERANCE | MELANOMA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GROWTH | GENES | GENETICS & HEREDITY | REGULATORY T-CELLS | MICE | SUPPRESSOR-CELLS | CARCINOMA | MACROPHAGE MARKERS | CD40 Antigens - antagonists & inhibitors | Receptors, TNF-Related Apoptosis-Inducing Ligand - antagonists & inhibitors | Chemokine CCL2 - immunology | Kidney Neoplasms - immunology | Interleukin-13 - immunology | Male | Kidney Neoplasms - metabolism | Receptors, TNF-Related Apoptosis-Inducing Ligand - immunology | Organ Specificity - immunology | Neoplasms - therapy | Prostate - immunology | Colonic Neoplasms - immunology | Immunotherapy | Neovascularization, Pathologic - immunology | Antibodies, Monoclonal - immunology | Macrophages - immunology | Disease Models, Animal | Gene Expression | Antibodies, Monoclonal - pharmacology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Neoplasms - mortality | Treatment Outcome | Tumor Microenvironment - immunology | Macrophages - metabolism | Animals | Antibodies, Monoclonal - administration & dosage | Neoplasms - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - antagonists & inhibitors | Cell Line, Tumor | Kidney Neoplasms - pathology | Mice | Neoplasms - pathology | CD40 Antigens - immunology | Original
Journal Article
PloS one, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e57911
Background: Immune evasion is one of the recognized hallmarks of cancer. Inflammatory responses to cancer can also contribute directly to oncogenesis. Since... 
BREAST-CANCER | METASTASIS | POLYMERIC IMMUNOGLOBULIN RECEPTOR | BIOMARKER | MULTIDISCIPLINARY SCIENCES | TISSUE | GENE-EXPRESSION | DOWN-REGULATION | KARYOPHERIN-ALPHA 2 | EPITHELIAL OVARIAN-CANCER | T-CELLS | Cell Adhesion Molecules - genetics | Colonic Neoplasms - genetics | Prognosis | Carcinoma, Squamous Cell - genetics | Humans | Gene Expression Regulation, Neoplastic | Databases, Genetic | Data Mining | Gene Expression Profiling | Inflammation - complications | Neoplasms - complications | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Neoplasms - genetics | Colonic Neoplasms - immunology | Adenocarcinoma - genetics | Colonic Neoplasms - mortality | Gene Expression | Adenocarcinoma - immunology | Neoplasms - mortality | Workflow | Inflammation - immunology | Carcinoma, Squamous Cell - immunology | Adenocarcinoma - complications | Colonic Neoplasms - complications | Head and Neck Neoplasms - immunology | Neoplasms - immunology | Carcinoma, Squamous Cell - complications | alpha Karyopherins - genetics | Inflammation - genetics | Head and Neck Neoplasms - complications | Head and Neck Neoplasms - genetics | Biomarkers, Tumor - genetics | Head and Neck Neoplasms - mortality | Neoplasm Staging | Adenocarcinoma - mortality | Cluster Analysis | Proteins | Immunohistochemistry | DNA microarrays | Analysis | Genes | Cancer | Ovarian cancer | Transcription factors | Ovarian carcinoma | Leukemia | Lung cancer | CXCL13 protein | Biochemistry | Genomes | Tissue analysis | Metastasis | Datasets | Liver cancer | Angiogenesis | Immunology | Colon cancer | Tumorigenesis | Colon | Neck | Protein transport | Pancreas | Bioinformatics | Immune system | Immunoglobulins | Head | Cytokines | Data processing | Inflammation | Breast cancer | CD36 antigen | Gene expression | Low level | Nuclear transport | Liquid oxygen | Biomarkers | Hypoxia | Molecular biology | Prostate | Prostate cancer
Journal Article
Transplantation, ISSN 0041-1337, 04/2014, Volume 97, Issue 8, pp. 817 - 825
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 10/2017, Volume 127, Issue 10, pp. 3796 - 3809
Macrophages are attracted to developing tumors and can participate in immune surveillance to eliminate neoplastic cells. In response, neoplastic cells utilize... 
MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | PANCREATIC DUCTAL ADENOCARCINOMA | NECROSIS-FACTOR | TGF-BETA | INITIATION | RESISTANCE | MECHANISMS | SENESCENCE | TUMORIGENESIS | CANCER-THERAPY | Immunologic Surveillance | MAP Kinase Kinase Kinases | Neoplasm Transplantation | Adenocarcinoma - pathology | Tumor Necrosis Factor-alpha - genetics | Growth Differentiation Factor 15 - immunology | NF-kappa B - immunology | Neoplasm Proteins - immunology | Male | Growth Differentiation Factor 15 - genetics | Neoplasms, Experimental - pathology | Signal Transduction - immunology | Heterografts | Neoplasms, Experimental - immunology | Neoplasms, Experimental - genetics | Tumor Necrosis Factor-alpha - immunology | Female | Adenocarcinoma - genetics | Neoplasm Proteins - genetics | Macrophages - immunology | Nitric Oxide - immunology | Macrophages - pathology | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - genetics | Signal Transduction - genetics | Mice, Knockout | Animals | NF-kappa B - genetics | Nitric Oxide - genetics | Pancreatic Neoplasms - immunology | Mice | Adenocarcinoma | NF-κB protein | Senescence | Transcription factors | Cytokines | Tumor cells | TAK1 protein | Cytotoxicity | Immunosurveillance | Metastasis | Kinases | Macrophages | Gene expression | Cancer therapies | Cell growth | Surveillance | Tumor necrosis factor | Pancreatic cancer | Nitric oxide | Xenografts | Tumor necrosis factor-TNF | Tumorigenesis | Prostate cancer | Apoptosis
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2018, Volume 115, Issue 19, pp. E4473 - E4482
Prostate cancer is a heterogeneous disease composed of divergent molecular and histologic subtypes, including prostate adenocarcinoma (PrAd) and neuroendocrine... 
Cell surface antigens | Prostate cancer | Immunotherapy | CELLS | PROTEIN | MULTIDISCIPLINARY SCIENCES | ANTIANDROGEN RESISTANCE | LINEAGE PLASTICITY | NEUROENDOCRINE DIFFERENTIATION | MONOCLONAL-ANTIBODY | TUMORS | prostate cancer | cell surface antigens | immunotherapy | CARCINOMAS | CARCINOEMBRYONIC ANTIGEN | EXPRESSION | Prostatic Neoplasms - metabolism | Humans | Gene Expression Regulation, Neoplastic | Neoplasm Proteins - immunology | Transcriptome | Carcinoembryonic Antigen - genetics | Carcinoma, Neuroendocrine - therapy | Male | Neoplasm Proteins - metabolism | Prostate - metabolism | T-Lymphocytes - transplantation | Carcinoembryonic Antigen - metabolism | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Prostate - immunology | Prostatic Neoplasms - genetics | Proteome - immunology | Cell Differentiation | Membrane Proteins - metabolism | Neoplasm Proteins - genetics | Carcinoma, Neuroendocrine - metabolism | GPI-Linked Proteins - immunology | Carcinoembryonic Antigen - immunology | Membrane Proteins - genetics | Cells, Cultured | Carcinoma, Neuroendocrine - genetics | Membrane Proteins - immunology | Proteome - analysis | GPI-Linked Proteins - metabolism | Carcinoma, Neuroendocrine - immunology | T-Lymphocytes - cytology | T-Lymphocytes - immunology | Antigens, Surface - immunology | Antigens, Surface - analysis | GPI-Linked Proteins - genetics | Care and treatment | Methods | Cancer | Biological Sciences | PNAS Plus
Journal Article
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 1/2016, Volume 113, Issue 3, pp. E319 - E327
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 19, pp. 3167 - 3175
Journal Article
Clinical and experimental immunology, ISSN 0009-9104, 03/2011, Volume 163, Issue 3, pp. 324 - 332
...Introduction The science of tumour immunology is based on the premise that antibodies and cytotoxic T lymphocytes (CTL) can distinguish cancer cells... 
MHC class I | CTL | T cell epitope | tumour antigen | immunotherapy | Tumour antigen | Immunotherapy | TUMOR-ANTIGENS | METALLOPROTEINASE | TACE | NECROSIS-FACTOR-ALPHA | IMMUNOLOGY | EGFR | PEPTIDES | DISINTEGRIN | GROWTH-FACTOR | T-CELLS | VACCINES | ADAM17 Protein | Prostatic Neoplasms - metabolism | ADAM Proteins - immunology | Breast Neoplasms - immunology | Gene Expression - genetics | Granzymes - metabolism | Humans | Male | Interferon-gamma - metabolism | Breast Neoplasms - metabolism | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Lymphocyte Activation - immunology | T-Lymphocytes - metabolism | Leukocytes, Mononuclear - immunology | Peptide Fragments - immunology | Antigens, Neoplasm - metabolism | Female | Membrane Proteins - metabolism | Ovarian Neoplasms - metabolism | Epitopes, T-Lymphocyte - immunology | Gene Expression Regulation, Neoplastic - physiology | T-Lymphocytes, Cytotoxic - immunology | Antigens, Neoplasm - genetics | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Membrane Proteins - genetics | Histocompatibility Antigens Class I - immunology | Membrane Proteins - immunology | Antigen Presentation - immunology | ADAM Proteins - metabolism | T-Lymphocytes, Cytotoxic - metabolism | Cell Line, Tumor | Ovarian Neoplasms - therapy | T-Lymphocytes - immunology | ADAM Proteins - genetics | Ovarian Neoplasms - immunology | Enzymes | Oncology, Experimental | HLA histocompatibility antigens | Breast cancer | Research | T cells | Immunity | Epidermal growth factor | Histocompatibility antigens | Analysis | Prostate cancer | Interferon gamma | Antigenic determinants | Cancer | Drug therapy | Medical research | Ovarian cancer | Antigen presentation | granzyme B | ADAM protein | Epidermal growth factor receptors | ADAM17 protein | Antibodies | Data processing | Lymphocytes T | Epitopes | Leukocytes | Cell surface | Cancer vaccines | Cell activation | Major histocompatibility complex | gamma -Interferon | Histocompatibility antigen HLA | Metalloproteinase | Translational Studies
Journal Article